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Abstract
The yeast Wickerhamomyces anomalus has been investigated for several years for its wide biotechnological potential,
especially for applications in the food industry. Specifically, the antimicrobial activity of this yeast, associated with the
production of Killer Toxins (KTs), has attracted a great deal of attention. The strains of W. anomalus able to produce KTs,
called ‘‘killer’’ yeasts, have been shown to be highly competitive in the environment. Different W. anomalus strains have
been isolated from diverse habitats and recently even from insects. In the malaria mosquito vector Anopheles stephensi
these yeasts have been detected in the midgut and gonads. Here we show that the strain of W. anomalus isolated from An.
stephensi, namely WaF17.12, is a killer yeast able to produce a KT in a cell-free medium (in vitro) as well as in the mosquito
body (in vivo). We showed a constant production of WaF17.12-KT over time, after stimulation of toxin secretion in yeast
cultures and reintroduction of the activated cells into the mosquito through the diet. Furthermore, the antimicrobial activity
of WaF17.12-KT has been demonstrated in vitro against sensitive microbes, showing that strain WaF17.12 releases a
functional toxin. The mosquito-associated yeast WaF17.12 thus possesses an antimicrobial activity, which makes this yeast
worthy of further investigations, in view of its potential as an agent for the symbiotic control of malaria.
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Introduction
Wickerhamomyces anomalus (formerly Hansenula anomala and Pichia
anomala) is a Saccharomycetes yeast with wide biotechnological
potential [1], traditionally used in the agro-food sector, as a
biopreservation agent, suitable to improve feed and food safety.
The suitability of W. anomalus as a biopreservation agent is certified
by the European Food Safety Authority (EFSA), with the
attribution of a qualified presumption of safety status at level-1
(QPS-1) [2]. Fields of application for this yeast include biocontrol,
food fermentation, biofuel production, and the production of
therapeutic molecules used in human medicine.
W. anomalus is highly tolerant to environmental stresses, and is
adapted to a wide range of growth conditions, in terms of
temperature (3–37uC), pH value (2–12) and osmolarity [3]. This
robustness makes this yeast highly competitive in many different
habitats. It has been isolated from very diverse sources, including
flowering plants, fruit skins, dairy and baked food products,
contaminated oil, salted foods, wastewater, marine environments,
human tissues and even the gut of insects (flies, beetles and
mosquitoes) [1].
An additional character displayed by W. anomalus is a wide
spectrum antimicrobial activity (something very unusual in yeasts),
being active against a variety of microorganisms including other
yeasts, filamentous fungi and bacteria [1]. Several inhibition
mechanisms have been proposed such as competition for nutrients,
production of ethyl acetate and direct killing by Killer Toxins
(KTs). The yeast ‘‘killer’’ phenomenon derives from the lethal
activity of KTs secreted by self-immune killer strains on sensitive
yeasts, expressing specific cell-wall KT receptors (KTRs) [4].
KTs are a group of glycoproteins with a variable molecular
weight, whose activity is characterized by a large range of optimal
pH and temperatures [5]. These antimicrobial properties make W.
anomalus a valuable bio-control agent on different substrates; for
example the inhibition of the fungus Botrytis cinerea on fruits [6,7],
and of Penicillium spp., Aspergillus spp. and Enterobacteriaceae on cereal
grain [8]. The mechanism of bacterial inhibition is yet unknown,
but it is likely that W. anomalus KTs (WaKTs) play a main role, as
demonstrated on different Gram-negative bacteria and fungi
[9,10]. Killer activity mediated by WaKTs has been well
characterized against sensible strains of fungi. For example,
WaKT-mediated inhibition was demonstrated in Candida albicans
both in vitro and in vivo [11–13]. Other studies highlighted that a
KT-derived ‘killer’ peptide (KP), characterized by a candidacidal
activity, aggregates on the surface of C. albicans cells, particularly
on budding scars, where b1,3-glucans (the major component of the
KTRs) are exposed [14]. KP has also been shown to be effective
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against Saccharomyces cerevisiae, including some strains resistant to
conventional antifungal drugs [15], and against a wide spectrum of
microbes beyond bacteria and fungi, including the protozoan
parasites Leishmania infantum, L. major and Acanthamoeba castellanii
[16,17].
The mechanism of action of WaKTs is mainly based on the
interaction with cell-wall carbohydrates, where b-glucanase-
induced hydrolysis of glucan into glucose is demonstrated [18].
In this context, several authors have investigated the b-glucanase
activity of WaKTs from different W. anomalus strains. In the strain
K (successfully applied as a bio-control agent against B. cinerea on
apple) and in killer strains isolated from olive brine, exoglucanase-
encoding genes are responsible for the toxic exo-b-1,3-glucanase
activity [19,20]. The same WaKT-mediated enzymatic activity in
the marine W. anomalus strain YF07b is directed against
pathogenic fungi of a crab [21]. Thus, arthropod-associated W.
anomalus could exert a protective function against pathogens, in
addition to the already demonstrated nutritional role (such as the
case of the mutualistic yeast-beetle association with a nutritional
dependence in the coleopteran Doubledaya bucculenta [22]). Among
insects, W. anomalus has also been detected in the inner body of
Drosophila sp.[23] and in mosquitoes of public health importance
[24]. Particularly, it has been shown to be associated with the
malaria vector Anopheles stephensi, where the yeast is present in the
midgut as well as in the gonads [25].The association between
Anopheles mosquitoes and W. anomalus deserves to be further
investigated, in order to explore the possibility that this yeast could
be developed as an agent for the symbiotic control (SC) of malaria
[26], in addition to other candidates for SC, such as the bacteria
Asaia spp. and Wolbachia, and the fungus Metarhizium robertsii [27–
29].The objective of this work is to investigate whether the W.
anomalus strain isolated from An. stephensi displays killer activity
against model microorganisms, and whether it produces a KT
antimicrobial molecule within the mosquito body.
Materials and Methods
Yeast Strains
Five strains belonging to the yeast species W. anomalus, C. albicans
and S. cerevisiae have been used: (i) WaF17.12 isolated from An.
stephensi mosquitoes [25], (ii) WaATCC 96603, (iii) WaUM3, (iv)
CaATCC 24433 and (v) ScATCC 2601. WaATCC 96603 and
WaUM3 were used as reference strains, since they are respectively
WaKT-producing (WaKT-resistant) and WaKT-non-producing
(WaKT-susceptible) strains [30,31]. The strain WaUM3 was used
both as negative control in the experiments aimed at studying the
expression of WaKT and susceptible target in antimicrobial assays.
CaATCC 24433 and ScATCC 2601 were selected as additional
WaKT-susceptible targets [32–34].
Mosquitoes
The experiments were performed using a colony of An. stephensi
(Liston) reared at University of Camerino (Italy). Mosquitoes were
maintained at standard aseptic conditions of 30uC and 95%
humidity. Larvae were grown in tanks filled with water containing
sterile minced commercial mouse food. The adults were fed with
5% sterile sugar solution. Specific diet for IFA assays is described
in a paragraph below.
Production of Crude WaKT Extracts
The strains WaF17.12, WaATCC 96603 and WaUM3 were
grown in culture conditions suitable to stimulate the production of
soluble toxins in liquid medium, as reported by I˙zgu¨ et al. (2006)
[33]: YPD broth (20 g/l peptone, 20 g/l glucose, 10 g/l yeast
extract), buffered at pH 4.5 or pH 8 with 0.1 M citric acid and 0.2
M K2HPO4, and incubated at 26uC for 36 h at 70 rpm [32]. The
yeast cells were removed by centrifugation at 2000 g 4uC for
10 min. The supernatants were filtered and concentrated 100-fold
using Pierce Concentrators (Thermo Fisher Scientific Inc,
Waltham, Massachusetts, USA) with a cut off of 9 kDa, by
centrifugation at 4uC for 5 h at 2000 g.
Western Blot Analysis of WaKT Crude Extracts
The crude WaKT extracts from WaF17.12, WaATCC 96603
and WaUM3 were analyzed by electrophoresis in 7% polyacryl-
amide gel, at 100 Volts for 4 h in a minigel system (Bio-Rad
Laboratories, Richmond, Calif., USA). Proteins were electrically
transferred to a polyvinylidene difluoride (PVDF) membrane at 30
Volts overnight. PVDF membrane was incubated for 1 h at room
temperature with 3% non-fat powdered milk in phosphate-
buffered saline (PBS) at pH 7.2 and 2% tween-20 (PBS-T).
Subsequently, the membrane was incubated at 37uC for 1 h with a
1:50 dilution of monoclonal antibody (mAb) KT4 produced
against a WaKT of W. anomalus ATCC 96603 [14,30] in PBS-T,
washed three times in PBS-T and incubated for 1 h at room
temperature with a secondary, peroxidase-conjugated, anti-mouse
Ab. After three washings with PBS-T, the membrane was
incubated 1 min with the proper substrate (Ablotlite, Euroclone,
Italy) and detected by ChemiDoc 2000R (Kodak, USA).
WaKT Activity Assays
The tests to evaluate the toxic activity of WaF17.12 on
susceptible yeast strains were preliminary performed using
supernatants from W. anomalus cultures against S. cerevisiae.
WaF17.12, WaATCC 96603 (positive control) and WaUM3
(negative control) were grown at conditions that stimulate WaKT
production, as previously described (see paragraph on the
Production of crude WaKT extracts), at pH 4.5. Then the three
supernatants were filtered and used as growing-media for the yeast
strain ScATCC 2601. S. cerevisiae was inoculated in fresh YPD
medium pH 4.5 for normal growth control. After an overnight
incubation at 26uC and 70 rpm, optical densities (OD) were
measured by a NanoDrop 1000 Spectrophotometer (Thermo
Fisher Scientific Inc, Waltham, Massachusetts, USA).
An antimicrobial assay was carried out on solid medium plate
against Asaia sp. (a-proteobacterium, Gram-negative), isolated
from An. stephensi mosquito [27]. An overnight Asaia culture, grown
in liquid GLY medium (25 g/l glycerol, 10 g/l yeast extract, pH 5)
at 30uC at 100 rpm, was diluted to 0.1 OD (107 cells/ml) in sterile
water and seeded on GLY agar plate (25 g/l glycerol, 10 g/l yeast
extract, 20 g/l agar pH 5). In accordance with Lopes et al. (2010)
[35], five microliters of three dilutions (109, 108 and 107 cell/ml) of
a WaF17.12 yeast culture, grown in stimulating conditions, were
spotted in duplicate and the plates were incubated for 72 h at
20uC. Five microliters of a WaUM3 culture (109 cell/ml) were
spotted as negative control. As positive control, the same
experiment was performed seeding ScATCC 2601 (susceptible
strain) on a YPD plate (10 g/l yeast extract, 20 g/l bacterial
peptone, 20 g/l glucose, 20 g/l agar, 0.03 g/l methylene blue).
After 72 h, plates were observed for the presence of inhibition halo
around the spots.
Further killer activity tests of strain WaF17.12 were carried out
against the susceptible strains CaATCC 24433 and WaUM3, using
WaKT crude extracts obtained from WaF17.12, WaATCC 96603
(positive control) and WaUM3 (negative control) at different pH
conditions (4.5 and 8); these WaKT crude extracts were prepared
as described above. The sensitive strains were grown overnight in
YPD medium buffered at pH 4.5 (CaATCC 24433 or WaUM3) or
Yeast Antimicrobial Toxin in Malaria Vector
PLOS ONE | www.plosone.org 2 May 2014 | Volume 9 | Issue 5 | e95988
pH 8 (WaUM3) with 0.1 M citric acid and 0.2 M K2HPO4. Cells
(105 per well) of each susceptible strain were spotted in a 96-well
microtiter plate and incubated with the three KT crude extracts at
a final concentration of 50X or 19X in YPD medium. To control
the normal growth of the susceptible strains, cells were incubated
with fresh YPD and free medium was spotted in additional wells to
rule out a possible environmental contamination. After 12 h of
incubation at 26uC, the toxic activity of crude extracts against the
susceptible strains was evaluated by checking cell morphology, cell
density (established by OD measure) and by analysing the cellular
vitality through a trypan blue assay on a Neubauer counting
chamber using a 40X optical microscope objective (Carl Zeiss
Axio Observer.Z1, Milan, Italy).
Statistical Analysis
All the above assays with crude extracts (50X or 19X) on the
susceptible strains CaATCC 24433 and WaUM3 were performed
in triplicates and vital cells/ml were counted twice. The analysed
data are thus those that derived from three cell counts for each
assay (using the means of the two counts for each assay). The data
from the cell counts were analyzed using the software GraphPad
(available at http://www.graphpad.com/) and statistical analysis
was performed using One Way ANOVA followed by Bonferroni’s
Multiple Comparison Tests. Statistical significance is expressed as
a p-value, p,0.05.
Analysis of WaKT Expression by In vitro and In vivo
Immunofluorescence Assays (IFA)
WaKT expression was tested by IFA using mAbKT4 both
in vitro on cultivated yeasts and in vivo within the mosquito body.
Strains WaF17.12, WaATCC 96603 (positive control) and
WaUM3 (negative control) were grown at the conditions that
stimulate toxin production (see paragraph on the Production of crude
WaKT extracts), at pH 4.5. Cells were then centrifuged at 2000 g for
10 min at 4uC and washed twice in PBS 1X, for the in vitro assay,
or three times in 9 g/l NaCl and resuspended in 50 g/l sucrose
solution at a concentration of 108 cells/ml to be added to the diet
of newly emerged adult mosquitoes, for in vivo assay. In the latter
experiment four cages were prepared containing mosquitoes fed
with: i) sterile sugar solution, ii) sugar solution added with
stimulated WaATCC 96603 cells, iii) sugar solution added with
stimulated WaF17.12 cells or iv) sugar solution added with
stimulated WaUM3 cells. After two days of feeding, the
mosquitoes were moved in new cages and fed with sterile sucrose
solution only. Hence, 10, 20, and 27 days post yeasts introduction
mosquitoes were analyzed. Around 60 organs (midguts and
gonads) were dissected and analyzed per each time point (total
171).
For IFA, cultivated yeast cells and dissected mosquito organs
were fixed on slides with 4% paraformaldehyde for 10 min at 4uC
and washed twice with PBS 1X. Organs were permeabilized with
0.5% Triton X-100 in PBS 1X for 10 min at room temperature
and washed three times with PBS 1X. The slides were incubated in
1% BSA in PBS 1X for 30 min at room temperature and,
successively, for 1 h at 37uC in mAbKT4 diluted 1:1000 in PBS
1X. After three washings in PBS 1X, they were incubated for
30 min at 37uC with anti-mouse IgG Alexa Fluor 594 conjugate
(Invitrogen, Life Technologies) diluted 1:100 in PBS 1X and
washed three times for 10 min with PBS 1X. Slides were mounted
with glycerol and visualized by an epifluorescent microscope (Carl
Zeiss Axio Observer.Z1, Milan, Italy).
Immunohistochemistry
Five mosquitoes from cages i, ii, iii and iv were analyzed for the
immunolocalization of WaKT. The abdominal segments were
excised and immediately fixed in 4% buffered formalin solution for
2 h at room temperature. After dehydration in a graded ethanol
series, the samples were cleared in xylene and embedded in
paraffin at 56–58uC. Sections (5 micron thick) were mounted on
gelatin-coated slides, rehydrated and processed for immunohisto-
chemical staining using the Vectastain ABC kit reagents (Vector
Laboratories, Burlingame, CA). After inactivation of the endog-
enous peroxidase (0.3% H2O2 in methanol for 30 min) and
blocking of endogenous avidin-binding activity (avidin-biotin
blocking kit; Vector Laboratories), sections were incubated for
30 min in normal goat serum diluted 1:5 with 1% bovine serum
albumin (BSA; Sigma, St. Louis, MO) in 0.05 M phosphate-
buffered saline (PBS), pH 7.6. Incubation of sections with the
monoclonal antibody mAbKT4 was performed at dilutions from
1:100 to 1:2,000 in PBS containing 1% BSA overnight at room
temperature, in a humid chamber. After washing, sections were
incubated with goat biotinylated anti-mouse IgG (1:200 in PBS)
for 45 min, followed by washing in PBS and treatment with the
avidin-biotin-peroxidase complex (1:100) for 45 min. After wash-
ing in PBS, the immunoreactive polypeptides were visualized in all
sections by incubation for 4 min with VIP substrate (Vector
Laboratories) and the reaction was stopped by rinsing with tap
water. Finally, sections were dehydrated and mounted in Eukitt.
Immunohistochemical controls were carried out by incubation
with preimmune serum or with PBS plus 1% BSA, in place of the
primary antibody. Analysis has been performed using a photomi-
croscope Leica DM2500.
Cloning and Sequencing of WaF17.12exoglucanase-
encoding Genes (EXG1 and EXG2)
Genomic DNA was extracted from a culture of the strain
WaF17.12 using a JetFlex kit (Genomed, Germany). Amplifica-
tions of EXG1 and EXG2 genes were obtained using specific
oligonucleotides (described in Table S1) designed on the W.
anomalus BS91 EXG1 and EXG2 sequences available in the data
bases (accessions: JQ734563 and JQ734566). Reaction mixtures
were prepared in 25 ml using: 0.6 U of Dream Taq Polymerase
(Fermentas, Thermo Fisher Scientific Inc, Waltham, Massachu-
setts, USA), 0.25 mMdNTPs, 1X Taq Polymerase Buffer, 0.2 mM
each primer and 50 ng DNA. Reactions were run for 2 min at
95uC and cycled 30 times through 30 sec at 95uC, 30 sec at 55uC
and 40 sec at 72uC. Finally, reactions were kept for 8 min at 72uC.
PCR products were then resolved in 1% agarose gel stained with
ethidium bromide. The fragments were cloned in T-Vector
System following manufacture’s instructions (Promega, USA).
The cloned fragments were sequenced after colony PCR using the
plasmid primers SP6 (59-atttaggtgacactatagaat-39) and T7 (59-
aatacgactcactataggg-39). The obtained sequences were firstly
analysed by BLASTN. (http://blast.ncbi.nlm.nih.gov/Blast.cgi).
Sequence alignment were then generated by ClustalW (http://
www.genome.jp/tools/clustalw/). Sequences of WaF17.12 genes
EXG1 and EXG2 were deposited through the EMBL-Bank.
Results
Characterization of WaF17.12-KT Using Monoclonal
Antibody KT4 (mAbKT4)
Western blot analysis was carried out on WaKT crude extracts
from the strains WaF17.12 (from An. stephensi), WaATCC 96603
(WaKT-producing strain) and WaUM3 (WaKT-non-producing
strain) cultivated at a growth condition that stimulates toxin
Yeast Antimicrobial Toxin in Malaria Vector
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production [32,33]. The monoclonal antibody (mAbKT4) used for
labelling was directed against a specific WaKT, produced by the
reference strain WaATCC 96603 and well characterised for its
wide antimicrobial activity; mAbKT4 has already been shown to
cross-react with the toxin produced by other strains of killer yeasts
[14,30]. Western blot analysis revealed a single band of the same
size in both WaF17.12 (mosquito strain) and WaATCC 96603
(positive control) KT crude extracts; no signal was present in the
extract from WaUM3 (negative control) (see Figure S1). These
results show that yeast strain WaF17.12 from An. stephensi [25]
releases a protein molecule in the cultivation medium that is
labelled by the monoclonal antibody directed against WaKT; this
indicates that WaF17.12 likely secretes a killer toxin.
Further evidence for the capacity of WaF17.12 to produce a
killer toxin was obtained by immunofluorescence assay (IFA) using
mAbKT4 in vitro, on free yeast cells, and in vivo, in the mosquito.
Staining with mAbKT4 produced a clear fluorescent signal onto
the cell surface of free yeast cells from strains WaF17.12 and
WaATCC 96603, while no signal was revealed in WaUM3
(Figure 1A, B and C respectively). Taken together, the results of
Western blot analysis and in vitro IFA on free cells are coherent,
and provide evidence that strain WaF17.12, once isolated from
mosquito and cultivated in stimulating conditions, produces
WaKT.
Afterwards, IFA assay was carried out in vivo in An. stephensi,
checking the toxin presence in mosquito organs that are known to
harbour W. anomalus [25]. Staining with mAbKT4 revealed very
occasional and faint WaKT signals within the analysed guts and
gonads. To investigate if the observed limited staining could derive
from a scarce production of the killer toxin in the mosquito body,
we carried out an in vivo IFA assay using mAbKT4 after feeding
mosquitoes with a sugar meal containing yeast cells stimulated
in vitro. Mosquitoes diet was supplemented for two days with
WaF17.12, WaATCC 96603 (WaKT-producing strain) or
WaUM3 (WaKT-non-producing strain), except a control group
fed on sterile sugar solution. After each yeast treatments
mosquitoes were fed on sterile sugar solution and were then
dissected for the recovery of the organs (guts and gonads) at
specific time points, for IFA observations. In table 1 are reported
the percentages of positive samples detected on the 10th, 20th or
27th day after each yeast treatments (detailed data on male and
female organs are given in table S2).
IFA analysis at different time points highlighted that both
WaF17.12 and WaATCC 96603, once stimulated in culture and
reintroduced in the mosquitoes, were characterized by an intense
WaKT signal. In the majority of the samples analyzed, WaKT
signal was detected up to four weeks after the introduction of the
yeast-enriched meal (Table 1). After WaF17.12 introduction,
fluorescence analysis revealed the presence of an abundant WaKT
signal in both female and male midguts (Figure 2A and B; see
also immunolocalization in Figure S2) and gonads (Figure 2C
and D). Similar staining was observed in the samples fed with the
reference strain WaATCC 96603 (not shown). In contrast, in
mosquitoes supplemented with WaUM3 and in the control group,
the percentages of positive samples are lower than in the other
mosquitoes and we observed only a few faintly stained yeast cells,
that might perhaps represent resident (not introduced) yeasts.
Figure 3 shows a comparison of the typical WaKT signal detected
in mosquitoes fed with WaF17.12 or with sterile sugar solution
only.
IFA analysis also revealed some differences between guts and
gonads: we observed that the WaKT signal on the 10th day was
detected almost exclusively in the guts, whereas in the following
two time points the number of positive gonads increased and
became comparable to that of the guts (Table S2).
Significant WaKT signal was detected even in part of the
offspring of WaF17.12 fed mosquitoes, suggesting a vertical
transmission of the yeasts and a long-term effect of the in vitro
induction of KT secretion (Figure S3).
Crude WaF17.12-KT Activity Assays
Experiments performed using yeast culture supernatants
showed antimicrobial activity of WaF17.12 against the susceptible
strain ScATCC 2601 [34], belonging to the species S. cerevisiae.
Specifically the growth of the target yeast ScATCC 2601 was
inhibited when inoculated in the liquid culture medium obtained
from the supernatants of WaATCC 96603 (WaKT-producing
strain) and WaF17.12 grown at condition that stimulate WaKT
production, but not using supernatant from WaUM3 (WaKT-non-
producing strain) (see Figure S4).
In-depth antimicrobial activity assays were carried out using
crude WaKT extracts from WaF17.12, WaATCC 96603 and
WaUM3 against two additional WaKT susceptible yeast strains,
CaATCC 24433 [32], belonging to the species C. albicans, and
WaUM3 itself [30,31]. The results obtained using different
concentrations of the crude extracts (50X and 19X) were
comparable and data about the lower concentration assay are
shown in figure 4 (those from the 50X concentration are not
shown). Since it is reported that WaKT activity shows its
maximum around acidic pH values, with a peak at pH 4.5
[21,33], this was the pH value used in assays for both sensitive
target strains (Figure 4A and B). To test possible killer activity at
not ideal pH conditions, we performed an additional assay at pH 8
(Figure 4C) on WaUM3, considering this target as the most
suitable one [4]. In the three assays the results of toxin activity
revealed a growth inhibition of both susceptible strains when
treated with WaKT crude extracts from WaF17.12 and WaATCC
96603, while no effect was detected with WaUM3 extract. More in
detail, cell counts of CaATCC 24433 (Figure 4A) and WaUM3
Figure 1. In vitro detection ofWaKT by IFA assay using mAbKT4. Free yeast cells of W. anomalus strains WaF17.12 (A), WaATCC 96603 (B) and
WaUM3 (C) are shown. Red signal showsWaKT concentrated in the yeast cell wall layers ofWaF17.12 (A) and WaATCC 96603 (B) (bars = 20 mm). Phace
contrast of panels A, B and C are shown in Figure S6.
doi:10.1371/journal.pone.0095988.g001
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(Figure 4B and C) showed a growth inhibition after treatment
with both of the crude extracts from the two WaKT-producing
strains (p,0.01, p,0.001 and p,0.01 respectively). These data
confirmed that the susceptibility of the two target strains to toxic
activity of WaF17.12 was comparable to that exerted by the
reference strain WaATCC 96603. Importantly, significant antimi-
crobial activity against WaUM3 was observed also at pH 8
(Figure 4C) although the toxic effect appeared to be lower than
those at acidic pH, in agreement with published results [33].
Bonferroni’s tests have been performed comparing the number of
cells/ml of the target strains after each treatment with crude
extracts from WaF17.12, or WaATCC 96603 (positive control),
versus treatment with crude extract from WaUM3 (negative
control).
Since a WaKT-mediated activity on Gram-negative bacteria
has been described [9], we investigated the effect of a culture
Table 1. In vivo detection of WaKTs in An. stephensi by IFA with mAbKT4.
Days after yeast introduction Mosquito feeding WaKT detection %( )u
10 (i) Sterile sugar solution 29% (5*/17)
(ii) Sugar solution plus WaATCC 50% (8/16)
(iii) Sugar solution plus WaF17.12 56% (9/16)
(iv) Sugar solution plus WaUM3 19% (3*/16)
20 (i) Sterile sugar solution 60% (9*/15)
(ii) Sugar solution plus WaATCC 93% (13/14)
(iii) Sugar solution plus WaF17.12 92% (11/12)
(iv) Sugar solution plus WaUM3 50% (8*/16)
27 (i) Sterile sugar solution 54% (7*/13)
(ii) Sugar solution plus WaATCC 83% (10/12)
(iii) Sugar solution plus WaF17.12 92% (11/12)
(iv) Sugar solution plus WaUM3 42% (5*/12)
Total samples analysed: 171
( )uWaKT positive organs/total organs analyzed.
*Occasional WaKT signals were detected in these samples.
doi:10.1371/journal.pone.0095988.t001
Figure 2. In vivo detection of WaF17.12-KT by IFA assay using mAbKT4. Red stained yeasts are visible in the mosquito organs after feeding
sugar solution supplemented with WaF17.12 cells cultivated in WaKT stimulating condition: Female (A) and male (B) guts analyzed on the 10th day
after yeast introduction (bar = 200 mm), female (C) and male gonads (D) analyzed respectively on the 20th and 27th day after yeast introduction
(bar = 50 mm). Negative control (gut treated with secondary antibody only) is shown in Figure S7.
doi:10.1371/journal.pone.0095988.g002
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WaF17.12 stimulated for KT production on the An. stephensi
bacterial symbiont Asaia sp., that is known to massively inhabit the
mosquito midgut and gonads [27]. The assays showed that the
growth of Asaia sp. colonies in vitro was not inhibited by the
WaF17.12, suggesting that this yeast does not exert its antimicro-
bial activity against Asaia symbionts (see Figure S5).
Sequence Analysis of WaF17.12 Exoglucanase-encoding
Genes EXG1 and EXG2
The EXG1 and EXG2 complete coding genes were amplified,
cloned and sequenced. We identified two Open Reading Frame
(ORF) sequences of 1497 bps and 1284 bps, respectively. Corre-
sponding amino acid sequences are of 499 residues in the case of
EXG1 and 428 for EXG2.
The EXG1 and EXG2 sequences showed a 100% and 99%
similarity respectively with the GenBank W. anomalus sequences
JQ734563 and JQ734566 [20]. Sequences of WaF17.12 EXG1
Figure 3. WaF17.12-KT fluorescence signal comparison in female mosquito midguts with or without yeast introduction. Female
mosquito midguts on the 10th day after feeding with sugar solution enriched with stimulated WaF17.12 (A and B) and sterile sugar solution (C and D).
Red stained yeasts are abundantly visible in (A), while only few cells are detected in the control sample (C). Images B and D (bar = 20 mm) are
magnification of samples shown in A and C respectively (bar = 200 mm) White arrow in A and C indicates the section of sample enlarged in B and D.
doi:10.1371/journal.pone.0095988.g003
Figure 4. CrudeWa F17.12-KT extract activity assays. The susceptible strains CaATCC 24433 (A) and WaUM3 (B and C) were incubated for 12 h
at 26uC at pH 4.5 (A and B) and 8 (C) with WaKT crude extracts (19X) from WaF17.12, WaATCC 96603 (WaKT-producing strain) or WaUM3 (WaKT non-
producing strain). Crude WaKT activity was evaluated using the trypan blue test reporting the number of vital cells/ml of the two target strains and
the values are reported as mean6SEM (n= 6). Asterisks refers to the statistical significance of the differences, according to the One Way ANOVA and
Bonferroni’s Multiple Comparation Tests.
doi:10.1371/journal.pone.0095988.g004
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and EXG2 genes were deposited through the EMBL-Bank under
the accession numbers HG316785 (EXG1) and HG316786
(EXG2).
Discussion
The Yeast Strain WaF17.12 Isolated from Mosquito
Secretes WaKT Both In vitro and In vivo
Western blot analysis of cultural crude extracts showed that
strain WaF17.12, isolated from the malaria vector An. stephensi,
releases a molecule in the medium that is stained by mAbKT4, a
monoclonal antibody targeted on killer yeast toxins. By in vitro IFA
assay on free cells, we verified that cultivated WaF17.12 yeasts also
produce a molecule recognized by mAbKT4, concentrated at the
surface of the yeast. This is in accordance with published results
indicating toxin secretion through the cell wall in W. anomalus
WaKT-producing strains [36,37]. Overall, the above results
strongly suggest that WaF17.12 yeast strain from mosquitoes
produces a killer toxin.
IFA analyses also pinpointed that when cultures of WaF17.12
stimulated for toxin production were reintroduced within the
mosquito by the diet, the WaKT signal was still present several
weeks after the yeast reintroduction, i.e. for the entire mosquito life
span (a relevant mAbKT4-staining was found even in the offspring
of these mosquitoes). Particularly, the toxin signal was detected in
the midgut and gonads, in both male and female mosquitoes. The
WaKT signal in mosquitoes fed with WaF17.12 (or the reference
strain WaATCC 96603) was quite abundant especially within the
female midgut. Instead, the mosquitoes fed with sterile sugar
solution or with WaUM3 showed few stained yeast cells.
Reasonably, this occasional WaKT signal could derive from the
presence of residing (not introduced) yeasts capable of producing
the toxin (and possibly related with WaF17.12).
Crude WaKT Extract from WaF17.12 shows In vitro
Antimicrobial Activity
Bio-assays demonstrated that WaF17.12 exhibits antimicrobial
effects against different susceptible strains, inhibiting their growth
in cultivation media. Similarly to other strains of W. anomalus that
have been described to be active against C. albicans, we
demonstrated that WaF17.12 exerted an antimicrobial effect
in vitro on a strain from this species, CaATCC 24433. Since
ascomycetous yeasts are frequently described to infect mosquitoes
[24,38,39], future studies could investigate the possible detrimental
effects of killer yeast strains against other yeasts sharing the same
habitat within the insect body.
WaKT activity assays at pH 4.5 and pH 8 demonstrated that
the killer activity of WaF17.12 against WaUM3 spans a wide range
of pH values. This finding fits well with possible antimicrobial
competition of W. anomalus in the mosquito body, since different
physiological conditions can occur in vivo, for example in the
different organs as well as at the intestinal level depending on the
diet. Particularly, it is described that pH in the female midgut can
vary around basic values after a blood meal [40,41]. Concerning
temperature, our experiments were carried out at 26uC, the
suggested condition for toxic assays [32]. Nevertheless, antimicro-
bial tests demonstrated that the maximum WaKTs activity ranges
from 18uC to 30uC and its decrement starts at around 40uC [33].
Adaptability of KT activity to different pH values and tempera-
tures is an important requisite for potential applications of killer
yeast strains in the biotechnological control of mosquito transmit-
ted diseases. In this context, the inefficacy of WaF17.12-KT
against Asaia sp. supports a feasible cohabitation of the bacteria
and the yeast in the mosquito midgut and gonads, suggesting the
possible synergistic use of W. anomalus in combination with other
microbial candidates for SC.
Exoglucanase-encoding Genes as Possible Mediators of
W. anomalus Killer Activity
Antimicrobial activity of toxins produced by killer yeasts is well
documented in literature [21,42,43], while little is known about
the genetics of this antimicrobial phenotype. Some indications
suggested that WaKTs are chromosomally inherited [44], but the
chromosomal localization of the genes is still missing [5]. Of
particular interest was the identification of genes responsible for
the synthesis of exo- b-1,3-glucanase [19] and the characterization
of its enzymatic activity, adapted to a wide range of temperature
and acidic pH [45–47]. This activity is responsible for the cleavage
of the b-glycosidic bond of b-glucan, a major cell wall component
of yeasts, [33]. Here, we reported the identification of two genes in
the mosquito yeast strain WaF17.12, EXG1 and EXG2, that
encode for exo-1,3-b-glucanases. Nevertheless hypothesis of a
possible association between antimicrobial phenotype of
WaF17.12with exo-b-1,3-glucanase activity needs further charac-
terization of these genes. Particularly, the amplification of both
EXG-genes also in the non-killer strain WaUM3 lays the basis for
later studies encompassing possible polymorphisms and differences
in the transcriptional activity of these genes in KT-producing and
non KT-producing strains. A clarification of this aspect may
contribute to explain the molecular basis of the killer phenome-
non.
Conclusions and Prospects for Future Applications
The results here reported show that mosquito yeast strain
WaF17.12: (i) secretes a molecule recognized by a monoclonal
antibody specific for killer yeast toxins; (ii) possesses antimicrobial
activity against sensitive yeast strains/species. This allows us to
conclude that the mosquito yeast WaF17.12 can be regarded as a
killer yeast, capable of producing a killer toxin. We would thus
indicate this toxin as WaF17.12-KT.
W. anomalus yeasts had been detected in mosquitoes a few years
ago, but their biological role in these insects is still unknown
[24,25]. Arthropod-associated W. anomalus strains could exert a
nutritional role [22] and/or a protective function mediated by
antimicrobial activity against pathogens [48], and this led us to
hypothesize that W. anomalus might play similar roles also in
mosquitoes [24,25]. The novel finding that the strain isolated from
An. stephensi displays an antimicrobial phenotype supports the
hypothesis of a protective function. The protective role of
symbiotic microorganisms against pathogens in different arthro-
pod species is emerging as a promising research field, with a high
potential for future applications toward the control of vector-borne
diseases [29,49]. However, most of the papers so far published in
this field deal with bacterial symbionts, and the work here
presented provides the first evidence for the presence of a yeast
expressing a killer phenotype in mosquitoes.
The presence of a W. anomalus killer strain in the female
mosquito midgut is quite interesting, considering that the gut
represents a numeric bottleneck during the life cycle of Plasmodium,
and this could make the parasites more vulnerable to the action of
antagonistic microorganisms [50]. Future studies should thus
investigate whether KT-producing strains of W. anomalus possess
anti-Plasmodium activity, and whether enough toxin is produced by
the yeasts naturally present in the mosquito gut. On the other
hand, our results show that cultivated yeasts can easily colonize
mosquitoes, and then continue with toxin production for at least
four weeks. Killer yeasts could also be selected for an increased
secretion of KT at conditions that simulates the mosquito gut, and
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for more effective anti-malaria activity. A possible association
between antimicrobial phenotype of KT-producing strains with
exo-b-1,3-glucanase seems very interesting, particularly consider-
ing that the enzyme target carbohydrate (b-1,3-glucan) is already
known to be present in some parasites oocyst walls as Toxoplasma
and Eimeria [51] and implicated in the immunoprotection against
Plasmodium berghei infection in mice [52].
Yeasts naturally effective against malaria (or even after selection
for increased activity) would likely be more easy to be accepted by
the public opinion for field applications, compared to the
genetically modified microorganisms foreseen by the so-called
paratransgenesis approach [53].
Data Accessibility
DNA sequences are accessible at http://www.ebi.ac.uk/ena/
data/view/HG316785-HG316786.
Supporting Information
Figure S1 Western blot analysis of WaKT crude ex-
tracts.WaF17.12, WaATCC 96603 (WaKT-producer strain) and
WaUM3 (WaKT-not-producer strain) crude extracts, obtained
after concentration of supernatants from yeast cultures stimulated
for WaKT secretion, were analyzed using mAbKT4. (1) Standard
molecular weight marker expressed in kDa and WaKT crude
extracts from (2) WaUM3, (3) WaATCC 96603 and (4) WaF17.12.
A single band at around 250 kDa was revealed in extracts from
WaATCC 96603 and WaF17.12.
(DOC)
Figure S2 Immunolocalization of WaF17.12-KT in An.
Stephensi abdominal sections. Abdominal histological sec-
tions of adult female mosquitoes treated with sterile sugar solution
(A) or with sugar solution enriched with stimulated yeast cultures
of WaF17.12 (B). White asterisk and black arrow in (B) indicate
positive staining surrounding the intestinal epithelium and the
presence of WaF17.12 cells in the midgut lumen (ML),
respectively. WaF17.12-KT signal in panel (B) is shown in the
mosquito gut on the 10th day post yeast treatment. mAbKT4 is
able to recognize both the WaF17.12-KT on the surface of the
yeast cell and in soluble form, as demonstrated by IFA and
Western blot analysis, respectively. Interestingly, the staining
obtained by immunohistochemistry appears to localize on both
yeast cells surface and intestinal epithelium, supporting the
hypothesis that WaF17.12-KT is secreted in vivo and present in
the gut lumen.
(DOC)
Figure S3 In vivo detection ofWaF17.12-KT in mosquito
offspring by IFA assay using mAbKT4. Red stained yeasts
are visible (white arrow) in the female mosquito midgut (F1
generation from parental mosquitoes fed for two days with sugar
solution plus stimulated WaF17.12 cells) (bar = 50 mm).
(DOC)
Figure S4 Antimicrobial activity of WaF17.12 against S.
cerevisiae. The susceptible strain ScATCC 2601 was inoculated
in fresh YPD medium (A) or in filtered broth culture surnatants of
the strains WaUM3 (B), WaATCC 96603 (C) and WaF17.12 (D)
grown at conditions that stimulate WaKT production. After an
overnight incubation at 26uC and 70 rpm, optical densities (OD)
of each ScATCC 2601 culture were measured. ScATCC 2601
growth rates compared to growth control (A) showed to be slightly
affected in (B), whereas there is a strong decrease in (C) and (D).
(A): 5.97 OD (26108 cells/ml*); (B): 3.83 OD (1.36108 cells/ml*);
(C): 1.04 OD (3.56107 cells/ml*); (D): 1.04 OD (3.56107 cells/
ml*). *Concentration (cells/ml) of ScATCC 2601 has been
evaluated by the assessment of a standard growth curve.
(DOC)
Figure S5 Growth inhibition evaluation ofWaF17.12-KT
against S. cerevisiae and Asaia sp. Cultures of ScATCC
2601 (A) and Asaia sp. (B) were seeded on YPD agar and GLY
agar, respectively. The plates were incubated for 72 h at 20uC
with three dilution of the activated WaF17.12 culture: 109 cells/ml
(1 and 4), 108 cells/ml (2 and 5) and 107 cells/ml (3 and 6).
WaUM3 culture (109 cell/ml) was spotted as negative control (N).
A growth inhibition halo is distinguishable surrounding the yeast
colonies only in the plate A (black arrow). The presence of a pink
ring of Asaia sp. around the yeast colonies (black arrow) can be
observed in plate B.
(DOC)
Figure S6 In vitro detection ofWaKT by IFA assay using
mAbKT4 (phase contrast of Fig. 1 in the main test). Free
yeast cells of W. anomalus strains WaF17.12 (A), WaATCC 96603
(B) and WaUM3 (C) phase contrast images corresponding to
images of Fig. 1 (A), (B) and (C) respectively.
(DOC)
Figure S7 In vivo detection of WaF17.12-KT by IFA
assay using mAbKT4 (negative control for IFA experi-
ments). Female gut from mosquito fed with cultivated WaF17.12
after treatment with secondary antibody only.
(DOC)
Table S1 Oligonucleotides used in EXG1 and EXG2
genes molecular analysis. List of primers used in EXG genes
sequence analysis.
(DOC)
Table S2 Detection of WaKT signal in mosquito organs
by IFA with mAbKT4. Four cages containing mosquitoes fed
with: (i) Sterile sugar solution, (ii) sugar solution enriched with
WaATCCC 96603 (WaKT-producing strain), (iii) sugar solution
enriched with WaF17.12 and (iv) sugar solution enriched with
WaUM3 (WaKT non-producing strain). Organs were dissected 10,
20 and 27 days after yeast introduction and analyzed using a
fluorescence microscope.
(DOC)
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